• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Pharma Supply Chains: From Fragile to Agile

    Advanced Manufacturing and a Roadmap to the Facility of the Future

    Solving Pharma’s Underlying Rebate Leakage Problem

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Revolutionizing Pharma’s Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Univercells Expands into the U.S. With New Offices in Andover, MA

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Sanner Group Opens Second Manufacturing Facility in China

    Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems

    "3 Key Trends" with Srinivasan Shanmugam
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Pharmaceutical Continuous Manufacturing: USP Technical Guide

    Mikart Expands Production and Packaging Capabilities

    Flavor Masking for Rx and OTC Drugs

    Prefilled Syringe Production: Filling a Need with Modern Equipment

    Making the Complex, Simple: A Roadmap for Your OSD Journey
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment

    Ionis, Roche Partner on RNA-targeted Programs for AD and HD

    Modern Partnerships with CROs

    Merck KGaA, Quris-AI Expand Collaboration

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges

    Rentschler Biopharma’s ATMP UK Facility Receives MHRA Approval

    Aurisco's Manufacturing Site in China Clears FDA Inspection

    LighthouseAI Secures $2.25M Investment to Grow Supply Chain Products

    Valisure, DoD Conduct Pharmaceutical Quality Risk Assessment Study
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    INCOG BioPharma Services

    Lannett CDMO

    Societal CDMO

    Quotient Sciences
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    U.S. Pharmacopeia (USP)

    INCOG BioPharma Services

    Lannett CDMO

    Societal CDMO

    Quotient Sciences
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Preclinical Partnerships

    Bill Barbo of Charles River discusses drug discovery and outsourcing trends in today’s market

    Preclinical Partnerships
    04.10.18
    Preclinical CROs are playing an increasingly vital role in helping to advance drug targets from the discovery phase into development. Partnerships with pharma and biopharma are growing and evolving as sponsors seek out the latest science, drug research technologies, and specialty services.
     
    As an example of partnerships becoming more comprehensive, Charles River recently entered a strategic collaboration with Nimbus Therapeutics aimed at advancing new programs in immunology, metabolic disorders and oncology from the discovery phase through to Investigational New Drug (IND) submission.
     
    Also, expanding access to the latest technologies is key for Charles River. InSphero AG and Charles River  entered a partnership under which Charles River will leverage InSphero’s 3D cell culture technology to extend its preclinical services using in vitro 3D InSight Tumor Microtissues derived from its existing PDX collection.
     
    Additionally, the company has several longstanding partnerships that were recently extended. One is with Chiesi Farmaceutici SpA in the field of respiratory disease under which Charles River provides drug discovery services including medicinal chemistry, ADME/DMPK studies, pharmaceutics, in vitro assays, in vivo models, and safety pharmacology studies, to help identify and test Chiesi’s candidates for preclinical development.
     
    Another discovery alliance is with Genentech, a member of the Roche Group, where Charles River provides medicinal chemistry, in vitro and in vivo biology, structural biology, and computer-aided drug design to help identify promising candidates for preclinical development.
     
    Bill Barbo, corporate executive vice president and chief commercial officer, Charles River Laboratories discusses drug discovery and outsourcing in the preclinical space and how the company is doing business in today’s market –KB
     
    Contract Pharma: Where do you see opportunities to further engage existing customers?
     
    Bill Barbo: We are fortunate to be operating in a robust business environment that provides us with excellent growth opportunities—both with existing and potential clients. Across the biopharmaceutical industry, we've seen a continued trend toward outsourcing all phases of the drug development process. As a contract research organization (CRO) with an integrated portfolio that spans the drug research process from target discovery through IND submission, we are uniquely positioned to support clients.
     
    In 2017 we worked on 80% of all drugs approved by the FDA. Our early Discovery unit brought over 78 development candidates forward for our clients.  We see and develop more molecules, drugs and drug candidates than any one of our clients ever could—this is a value proposition for clients as they continue to increase their engagement with us across our portfolio.
     
    We work with a variety of clients across pharma, non-pharma, biotech and academia, and our true power is in our expertise. Our scientific bench and deep industry experience allow us to function as more than just a supplier or vendor—we work with clients as a strategic advisor, with access to a global infrastructure of industry-leading technologies.
     
    CP: Are you seeing any new collaboration models with the potential to disrupt traditional outsourcing?
     
    BB: Yes! We are seeing trends towards more strategic, integrated partnerships and outsourcing models, as opposed to the more traditional transactional CRO/client relationships. We've focused on broadening our portfolio through strategic acquisitions, the licensing of emerging technologies and continued internal development. Ultimately, this enables us to develop strategic partnerships, meaning that we are working side-by-side with clients, creating tailored solutions and flexible partnering models that allow us to support critical go/no-go decisions in their development pipeline faster and more efficiently then they can do it internally or with any other partner.
     
    CP: What is and isn’t working well in partnership models?
     
    BB: What’s working well is our approach and focus ondeveloping those more strategic partnership models, built on a highly collaborative, proactive platform, which is dramatically improving both the speed and throughput of drug discovery and development. These partnerships allow us to bring our scientific insight and input to the table, with the ultimate goal of enhancing the efficiency and effectiveness of outsourcing.
    Related Searches
    • collaboration
    • Development
    • Contract Research
    • Contract research organization
    Suggested For You
    Charles River Laboratories Charles River Laboratories
    Curia Curia
    Aurion Biotech Makes Strategic Investments in Manufacturing Aurion Biotech Makes Strategic Investments in Manufacturing
    Discovery Life Sciences Appoints Cell & Gene Therapy CTO Discovery Life Sciences Appoints Cell & Gene Therapy CTO
    Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer
    Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug Candidate
    Albumedix Extends Research Collaboration with Cobra Biologics Albumedix Extends Research Collaboration with Cobra Biologics
    Charles River Acquires Retrogenix Charles River Acquires Retrogenix
    Charles River Acquires CDMO Cognate BioServices Charles River Acquires CDMO Cognate BioServices
    Executive Moves at Frontage Executive Moves at Frontage
    Charles River Partners with JADE Charles River Partners with JADE
    Charles River Labs Acquires Distributed Bio Charles River Labs Acquires Distributed Bio
    PathoQuest, Charles River Expand Strategic Pact PathoQuest, Charles River Expand Strategic Pact
    Softweb Solutions Softweb Solutions
    Charles River, PathoQuest Expand Strategic Biologics Pact Charles River, PathoQuest Expand Strategic Biologics Pact

    Related Buyers Guide Companies

    • Charles River Laboratories

      Charles River Laboratories

      ...
      Genevieve Glazier, Director Safety Assessment Marketing 12.05.22

    • cGMP Manufacture | Chemistry
      Curia

      Curia

      ...
      Lubna Hussain, Director of Marketing 11.10.21

    • Breaking News | Industry News | Promotions & Moves
      Aurion Biotech Makes Strategic Investments in Manufacturing

      Aurion Biotech Makes Strategic Investments in Manufacturing

      Appoints Tim Largen as VP of manufacturing to drive cell therapy production strategy and direct collaborations with leading CDMOs.
      09.14.21


    • Biologics, Proteins, Vaccines | Breaking News | Promotions & Moves
      Discovery Life Sciences Appoints Cell & Gene Therapy CTO

      Discovery Life Sciences Appoints Cell & Gene Therapy CTO

      Dr. Clarke will work to further establish the company as a global leader in cell and gene therapy materials and analytical services.
      08.12.21

    • Breaking News | R&D
      Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer

      Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer

      The appointment forms part of the company’s growth strategy for 2021 and 2022, with a focus on the USA, EU and Japan.
      07.26.21

    Loading, Please Wait..
    Breaking News
    • Univercells Expands into the U.S. With New Offices in Andover, MA
    • Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    • Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    • Sanner Group Opens Second Manufacturing Facility in China
    • Körber Integrates Werum PAS-X MES with Bausch+Ströbel Systems
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Pharma Supply Chains: From Fragile to Agile
    • Overcoming Stressors in Knowledge Transfer
    • Innovations in Pharma Packaging
    • HPAPI Manufacturing Trends
    • Sustainable Packaging in Pharma: No Longer a Pipe Dream
    • Revolutionizing Pharma’s Supply Chain
    • Pharmaceutical Labeling: Overcoming Regulatory & Operational Challenges
    • Solving Pharma’s Underlying Rebate Leakage Problem
    • Advanced Manufacturing and a Roadmap to the Facility of the Future
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    D2C Supplement Brand Launches Blood Sugar Support Supplement, Gluco-Control
    Natrol Launches First Non-Melatonin Sleep Supplement
    Metagenics Releases Consumer Survey on Menopausal Support Supplement
    Coatings World

    Latest Breaking News From Coatings World

    Coating Additives Market Worth $10.5B by 2028: MarketsandMarkets
    California Sports Surfaces Celebrates 70 Years
    ROSS Offers Cost-Effective, Expertly Reconditioned Equipment
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Sept. 30
    Dentsply Sirona Names Former NuVasive CEO Lucier as Chairman
    SeaStar Medical Gets Breakthrough Nod for Selective Cytopheretic Device
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Univercells Expands into the U.S. With New Offices in Andover, MA
    Evecxia Therapeutics, Quotient Sciences Complete Clinical Milestone for Depression Treatment
    Ionis, Roche Partner on RNA-targeted Programs for AD and HD
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    MAV Beauty Recruits Former Elizabeth Arden CEO Scott Beattie
    YSL Beauty Taps Finn Wolfhard, Lil Yachty & More for Fragrance Campaign
    74% of Makeup Users Open to Affordable ‘Dupes,’ Mintel Says
    Happi

    Latest Breaking News From Happi

    Is Dr. Barbara Sturm Skincare Considering a Sale?
    YSL Beauty Welcomes Five Foremost Artists to Represent New Fragrance
    Christian Siriano Appointed Olay’s First Chief Drop Officer
    Ink World

    Latest Breaking News From Ink World

    MicroDynamics, All Printing Resources Partner to Represent Veritas
    Weekly Recap: Wikoff Color, BASF, Latin America Top This Week’s Stories
    Siegwerk’s Climate Targets Validated by SBTi
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    SABIC and partners launch bio-based IML solution for food packaging
    tesa completes expansion of Michigan manufacturing facility
    Comexi and Asahi to host 'Effortless Platemaking' event
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Greentech Introduces Air Filter with Advanced Odor Elimination
    Ontex Divests Pakistan Operations to ASAIA Holding
    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Sept. 30
    Lazurite Adds Benchmark Medical as a Distributor for its ArthroFree Wireless Camera System
    ChitogenX Granted New U.S., Canadian ORTHO-R Patent
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Mergers and Acquisitions, First Solar Top This Week’s Stories
    Jabil Posts Fourth Quarter, Fiscal Year 2023 Results
    Ink-Borne ‘Chiplets’ Could Lead to Printable Displays, Electronics and More

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login